Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.2900 (-3.61%) ($12.2900 - $12.2900) on Fri. Sep. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.05% (three month average) | RSI | 32 | Latest Price | $12.2900(-3.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.3% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) URA(32%) VUG(32%) XLK(32%) VT(31%) BLOK(29%) | Factors Impacting BCRX price | BCRX will decline at least -2.025% in a week (0% probabilities). VIXM(-14%) UUP(-13%) SMH(-12%) EDOC(-4%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.025% (StdDev 4.05%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.05(-50.77%) | Resistance Level | $13.47 | 5 Day Moving Average | $13.01(-5.53%) | 10 Day Moving Average | $13.12(-6.33%) | 20 Day Moving Average | $13.47(-8.76%) | To recent high | -17.1% | To recent low | 21% | Market Cap | $2.168b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |